Smokeless tobacco topography and toxin exposure

Nicotine and Tobacco Research

Volumn 7, Issue 3, 2005, Pages 469-474

  Lemmonds, Charlotte A ^a   Hecht, Stephen S ^a   Jensen, Joni A ^a   Murphy, Sharon E ^a   Carmella, Steven G ^a   Zhang, Yan ^a   Hatsukami, Dorothy K ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CARCINOGEN; COTININE; GLUCURONIDE; NICOTINE; TOXIN;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SMOKELESS TOBACCO; TOBACCO DEPENDENCE; TOPOGRAPHY; URINALYSIS;

ADULT; AGED; CARCINOGENS; HUMANS; MALE; MIDDLE AGED; MINNESOTA; REGRESSION ANALYSIS; TOBACCO, SMOKELESS;

EID: 26444541325     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200500135640     Document Type: Article

References (21)

1. Benowitz, N. (Ed.). (1998). Nicotine safety and toxicity. New York: Oxford University Press.
2. Carmella, S. G., Han, S., Fristad, A., Yang, Y., & Hecht, S. S. (2003). Analysis of total 4-(methylnitrosamino)-1-(3-pyridal)-1-butanol (NNAL) in human urine. Cancer Epidemiology, Biomarkers & Prevention, 12, 1257-1261.
3. Grunbaum, J. A., Kann, L., Kinchen, S., Ross, J., Hawkins, J., Lowry, R., Harris, W. A., McManus, T., Chyen, D., & Collins, J. (2003). Youth risk behavior surveillance-United States, 2003. Morbidity and Mortality Weekly Report Surveillance Summaries, 53(S502), 1-96.
4. Hatsukami, D. K., Anton, D., Callies, A., & Keenan, R. (1991). Situational factors and patterns associated with smokeless tobacco use. Journal of Behavioral Medicine, 14, 383-396.
5. Hatsukami, D. K., Edmonds, A., Schulte, S., Jensen, J., Le, C., Losey, L., Carmella, S. G., & Hecht, S. S. (2003). Preliminary study on reducing oral moist snuff use. Drug and Alcohol Dependence, 70, 215-220.
6. Hatsukami, D. K., Gust, S. W., & Keenan, R. (1987). Physiologic and subjective changes from smokeless tobacco withdrawal. Clinical Pharmacology and Therapeutics, 41, 103-107.
7. Hatsukami, D. K., Keenan, R. M., & Anton, D. J. (1988). Topographical features of smokeless tobacco use. Psychopharmacology, 96, 428-429.
8. Hatsukami, D. K., Lemmonds, C., & Tomar, S. (2004). Smokeless tobacco use: Harm reduction or induction approach? Preventive Medicine, 38, 309-317.
9. Hecht, S. S. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical Research in Toxicology, 11(6), 559-603.
10. Hecht, S. S. (2002). Human urinary carcinogen metabolites: Biomarkers for investigating tobacco and cancer. Carcinogenesis, 23, 907-922.
11. Hecht, S. S., Carmella, S., Chen, M., Koch, J., Miller, A., Murphy, S., Jensen, J. A., Zimmerman, C. L., & Hatsukami, D. K. (1999). Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Research, 59, 590-596.
12. Hecht, S. S., Carmella, S., Ye, M., Le, K., Jensen, J., Zimmerman, C., & Hatsukami, D. K. (2002). Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Research, 62(1), 129-134.
13. Hecht, S. S., & Hoffmann, D. (1988). Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-884.
14. Hecht, S. S., & Hoffmann, D. (1989). The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surveys, 8, 273-294.
15. Hoffmann, D., Djordjevic, M. V., Fan, J., Zang, E., Glynn, T., & Connolly, G. N. (1995). Five leading U.S. commercial brands of moist snuff in 1994: Assessment of carcinogenic N-nitrosamines. Journal of the National Cancer Institute, 87, 1862-1869.
16. International Agency for Research on Cancer. (1985). Tobacco habits other than smoking: Betel-qid and areca nut chewing and some related nitrosamines (Vol. 37). Lyon, France: Author.
17. Kresty, L. A., Carmella, S. G., Borukhova, A., Akerkar, S. A., Gopalakrishnan, R., Harris, R. E., Stoner, G. D., & Hecht, S. S. (1996). Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: Relationship of urinary biomarkers and oral leukoplakia. Cancer Epidemiology, Biomarkers & Prevention, 5, 521-525.
18. Severson, H. H., Eakin, E. G., Lichtenstein, E., & Stevens, V. J. (1990). The inside scoop on the stuff called snuff: An interview study of 94 adult male smokeless tobacco users. Journal of Substance Abuse, 2, 77-85.
19. Substance Abuse and Mental Health Services Administration. (2002). Results from the 2001 National Household Survey on Drug Abuse. Rockville, MD: Office of Applied Studies, Department of Health and Human Services.
20. U.S. Department of Health and Human Services. (1986). The health consequences of using smokeless tobacco: A report of the advisory committee to the surgeon general. Bethesda, MD: Author.
21. Vainio, H., & Weiderpass, E. (2003). Smokeless tobacco: Harm reduction or nicotine overload? European Journal of Cancer Prevention, 12, 89-92.